GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » COGS-to-Revenue

HLB Science (XKRX:343090) COGS-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science COGS-to-Revenue?

HLB Science's Cost of Goods Sold for the three months ended in . 20 was ₩0.00 Mil. Its Revenue for the three months ended in . 20 was ₩0.00 Mil.

HLB Science's COGS to Revenue for the three months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. HLB Science's Gross Margin % for the three months ended in . 20 was N/A%.

HLB Science COGS-to-Revenue Historical Data

The historical data trend for HLB Science's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science COGS-to-Revenue Chart

HLB Science Annual Data
Trend Dec22 Dec23
COGS-to-Revenue
- -

HLB Science Quarterly Data
COGS-to-Revenue

HLB Science COGS-to-Revenue Calculation

HLB Science's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

HLB Science's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HLB Science  (XKRX:343090) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

HLB Science's Gross Margin % for the three months ended in . 20 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

HLB Science COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of HLB Science's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science (XKRX:343090) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » COGS-to-Revenue
Comparable Companies
XKRX:950220 XKRX:283100 XKRX:322970 XKRX:215380 XKRX:179530 XKRX:446440 XKRX:251280 XKRX:208340 XKRX:344860 XKRX:072520 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
Website
http://www.hlbscience.com
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines